Welcome to our dedicated page for Stepan SEC filings (Ticker: SCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Stepan Company (NYSE: SCL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the details. As a public issuer in the specialty and intermediate chemicals space, Stepan files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that describe its surfactants, polymers and specialty products businesses, financial results and governance matters.
In Stepan’s 10-K and 10-Q filings, readers can review segment information for surfactants, polymers and specialty products, along with discussions of sales volumes, selling prices, raw material cost pass-through, product mix and operating income. These reports also cover topics such as the company’s global manufacturing footprint in North and South America, Europe and Asia, and its role as a leading merchant producer of surfactants and supplier of polyurethane polyols for thermal insulation and CASE markets.
Form 8-K current reports provide updates on specific events, including quarterly earnings releases, dividend declarations, executive appointments or departures, board changes and adoption of plans such as the Key Executive Severance Benefit Plan. These filings give timely insight into Stepan’s capital allocation, leadership structure and key corporate actions.
Stock Titan enhances access to Stepan’s filings with AI-generated summaries that highlight the most important points in lengthy documents, helping users quickly understand complex financial and legal language. Real-time updates from EDGAR ensure that new Stepan filings appear promptly, while dedicated views for insider transaction reports (Form 4), proxy statements (Schedule 14A) and other forms allow deeper analysis of executive compensation, ownership changes and governance practices. This page serves as a focused resource for anyone researching SCL through its official SEC record.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting that it may be deemed to beneficially own 1,123,035 shares of Stepan Co common stock, representing 5.0% of the class as of the event date. Dimensional has sole power to vote 1,090,399 shares and sole power to dispose of 1,123,035 shares. The shares are owned by various investment funds and accounts it advises (the “Funds”), and Dimensional disclaims beneficial ownership, stating the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Stepan Co.
Stepan Company director F. Quinn Stepan Jr. reported exercising 34,741 employee stock options on January 13, 2026 at an exercise price of $43.85 per share. The options converted into the same number of Stepan common shares in an exercise-and-hold transaction, leaving him with 160,960.262 common shares held directly.
In addition to these directly held shares, the filing lists various indirect holdings of Stepan common stock through entities such as a family LLC, several family trusts, an ESOP trust, and accounts associated with his spouse and other family members. For certain of these positions, he disclaims beneficial ownership except to the extent of any pecuniary interest, and some shares are held in estates or plans where he serves in an administrative role.
Stepan Company insider Luis Rojo, who serves as President & CEO and a director of Stepan Company, reported routine equity compensation activity. On 12/31/2025, restricted stock units (RSUs) covering 4,202 shares were settled in Stepan common stock at a price of $47.205 per share, consistent with the award terms. Each RSU represents a right to receive one share of Stepan common stock.
To cover tax obligations arising from the RSU vesting, 1,232 RSUs were withheld at a price of $47.205 per share. Following these transactions, Rojo beneficially owned 15,194.901 shares of Stepan common stock directly, 511.83 shares indirectly through the Esop II Trust, and continued to hold 7,175 RSUs and other derivative equity interests.
Stepan Company executive Robert Haire reported equity award activity involving Stepan Co. (SCL) common stock. On 12/31/2025, restricted stock units (RSUs) were settled in shares of common stock, resulting in the acquisition of 1,891 shares at a price of $47.205 per share. After this transaction, Haire beneficially owned 2,482 shares of common stock directly and 90.269 shares indirectly through an ESOP II Trust.
In connection with the RSU vesting, 574 RSUs were withheld to satisfy tax liabilities, leaving 1,318 RSUs beneficially owned following the reported transactions. Each RSU represents a contingent right to receive one share of Stepan Company common stock, and these RSUs vest ratably over two years beginning on the date shown.
Stepan Co director reports an insider stock transaction. A director of Stepan Co (ticker SCL) filed a Form 4 for a transaction dated 12/23/2025. The filing shows a gift transaction (code G) of 95.858 shares of Stepan common stock at a stated price of $0, reflecting a transfer without consideration. After this transaction, the director directly beneficially owns 126,219.262 shares of Stepan common stock.
The report also lists extensive indirect holdings in Stepan common stock through various vehicles, including an ESOP II trust, multiple family limited liability companies and family trusts, a spouse, a father, and an estate, with certain interests expressly disclaimed except to the extent of any pecuniary interest.
Stepan Company executive Richard F. Stepan, V.P. and General Manager of Polymers, reported an insider transaction involving the company’s common stock. On 12/23/2025, he reported a transaction coded "G," indicating a gift of shares at a price of
In addition to his direct holdings, the filing lists indirect ownership through family members and trusts, including shares held by a daughter, a son, a spouse, a trust, and an ESOP II trust. This Form 4 reflects a change in how some shares are held and reported, rather than a market sale or purchase for cash.
Stepan Company has approved a new Key Executive Severance Benefit Plan effective November 26, 2025. The plan covers selected executives, including currently serving named executive officers, and is intended to provide severance compensation and benefits following certain involuntary terminations described as Qualifying Terminations.
Qualifying Terminations include an involuntary termination without cause and certain terminations that occur on or within 24 months after a change in control, including constructive terminations. Tier 1 executives are eligible for severance periods of 18 months for an involuntary termination without cause and 36 months for a change in control termination, while Tier 2 executives receive 12 months and 24 months, respectively. Severance is conditioned on the executive signing a release and complying with restrictive covenants, and equity awards continue to be governed by existing equity incentive plans and award agreements.
Stepan Company (SCL) — Officer equity grants reported. On 11/07/2025, the VP & CHRO reported awards of 1,159 Restricted Stock Units, 1,638 Stock Appreciation Rights with an exercise price of $43.15, and 579 performance shares.
The RSUs and SARs vest ratably over three years beginning 11/07/2026; the RSUs expire 11/07/2028 and the SARs expire 11/07/2035. The performance shares vest upon certification of performance goals for the period ending December 31, 2027.
Stepan Company (SCL) filed its quarterly report, showing mixed Q3 results. Net sales rose to $590,284,000, but net income declined to $10,839,000, with diluted EPS of $0.47. Operating income was $21,794,000 as higher interest expense weighed on results.
For the nine months, net sales reached $1,778,228,000 while net income was $41,891,000 with diluted EPS of $1.83. Cash and cash equivalents were $118,537,000, and total debt was $655,472,000. Operating cash flow was $87,891,000 and capital expenditures were $87,896,000.
By segment in Q3, Surfactants delivered $15,718,000 operating income, Polymers $14,104,000 and Specialty Products $9,634,000, offset by unallocated corporate expenses. Accumulated other comprehensive loss improved to $(138,608,000). The company recorded environmental and legal accruals of $19,406,000 and paid a $1,126,000 USEPA civil penalty, recovering $500,000. Assets held for sale include SPQI’s Philippines manufacturing assets with $8,476,000 of assets and $4,571,000 of liabilities, with closing planned in the fourth quarter of 2025.
Stepan Company announced it issued a press release with its financial results for the quarter ended September 30, 2025, and disclosed a separate dividend action.
The Board of Directors declared a quarterly cash dividend of $0.395 per share, payable on December 15, 2025, to shareholders of record as of November 28, 2025. The earnings press release is furnished as Exhibit 99.1, and the dividend press release is furnished as Exhibit 99.2.